Undervalued Stocks Based On Cash Flows

Results

32

3 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

32 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
1801
HK$86.00-3.7%-7.4%HK$149.7bHK$117.76158.532.4%n/aPharmaceuticals & Biotech
2259
New
HK$117.00-1.3%n/aHK$310.5bHK$200.1717.818.2%1.3%Materials
6185
HK$23.14-1.1%-47.8%HK$9.8bHK$50.454.457.2%0%Pharmaceuticals & Biotech
9926
HK$91.85-6.8%-39.6%HK$84.6bHK$169.7123.846.2%n/aPharmaceuticals & Biotech
2315
HK$52.45-3.0%99.1%HK$48.1bHK$62.0369.541.0%n/aPharmaceuticals & Biotech
2252
HK$21.26-1.0%5.8%HK$21.6bHK$36.0734.390.9%n/aHealthcare
3696
HK$42.02-12.0%n/aHK$24.1bHK$80.6554.5114.1%n/aPharmaceuticals & Biotech
1364
HK$23.125.7%-4.9%HK$55.0bHK$30.8515.213.3%2.2%Consumer Services
697
HK$1.807.1%-3.2%HK$14.6bHK$2.6647.137.3%2.1%Real Estate Management and Development
1318
HK$55.80-1.2%-44.2%HK$27.4bHK$98.4419.617.2%2.1%Household
1521
New
HK$1.215.2%-17.1%HK$2.5bHK$0.9746.125.0%n/aPharmaceuticals & Biotech
1866
HK$9.180.05%38.4%HK$13.3bHK$12.8812.325.4%4.1%Materials
6656
HK$308.804.0%n/aHK$76.8bHK$621.2122.732.7%0.9%Capital Goods
2235
HK$6.94-2.0%3.3%HK$2.9bHK$11.8361.845.0%n/aHealthcare
2268
HK$52.15-4.0%-9.4%HK$66.0bHK$82.8738.425.5%n/aPharmaceuticals & Biotech
9658
HK$10.640.8%-30.4%HK$6.9bHK$14.4530.930.5%n/aConsumer Services
2145
HK$29.064.2%-64.7%HK$11.6bHK$86.219.016.7%5.0%Household
3858
HK$53.35-6.9%n/aHK$24.3bHK$96.4879.750.2%n/aMaterials
2698
HK$34.447.7%n/aHK$21.3bHK$39.7522.515.4%2.0%Household
3277
HK$63.30-7.1%n/aHK$28.1bHK$115.3582.534.2%0.5%Tech
1357
HK$4.7720.8%-59.7%HK$21.7bHK$8.9725.531.3%2.1%Media
1797
HK$22.28-1.7%-5.4%HK$23.5bHK$29.4859.224.7%n/aConsumer Retailing
2506
HK$68.603.0%-32.1%HK$8.3bHK$103.437.854.0%n/aHealthcare
1768
HK$385.4012.2%n/aHK$84.0bHK$507.9331.025.5%n/aConsumer Retailing
Page 1 of 1